Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.

摘要: Background It is estimated that millions of North Americans would qualify for lung cancer screening and billions dollars national health expenditures be required to support population-based computed tomography programs. The decision implement such programs should informed by data on resource utilization costs. Methods Resource were collected prospectively from 2059 participants in the Pan-Canadian Early Detection Lung Cancer Study using low-dose (LDCT). Participants who had 2% or greater risk over 3 years a prediction tool recruited seven major cities across Canada. A cost analysis was conducted Canadian public payer's perspective resources used treatment initial study. Results average per-person individuals with LDCT $453 (95% confidence interval [CI], $400–$505) 18-months following baseline scan. costs highly dependent detected nodule size, presence cancer, intervention, center. mean treating curative surgery $33,344 CI, $31,553–$34,935) 2 years. This lower than advanced-stage chemotherapy, radiotherapy, supportive care alone, ($47,792; 95% $43,254–$52,200; p = 0.061). Conclusion In study, screen high developing intent advanced stage which infrequently results cure.